However, most chemotherapy agents exert their cytotoxic effects by elevating the OS levels in the breast carcinoma, increasing OS damage to a level that the cancer cells cannot cope with and leading to cell death.13, 15 To this point, the originally protective effect of ROS might cause “resistance” to chemotherapy for the GSTM1‐present patients. This evidence concerns the gene GSTM1 and cancer.